Quick Answer
Mosaic ImmunoEngineering Inc. reported Stockholders Equity of -$6.79 million for the year ending 2024.
- Mosaic ImmunoEngineering Inc. showed a decrease of -15.6% in Stockholders Equity from 2023 to 2024.
- This data is from Mosaic ImmunoEngineering Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2010 to 2024 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $10.91 million | Q4 2011: $9.89 million | Q1 2012: $8.62 million | Q3 2012: $6.18 million | Q4 2012: $7.34 million | Q1 2013: $6.42 million | Q3 2013: $7.71 million | Q4 2013: $7.74 million | Q1 2014: $7.30 million | Q3 2014: $5.92 million | Q4 2014: $5.48 million | Q1 2015: $5.51 million | Q3 2015: $4.94 million | Q4 2015: $4.85 million | Q1 2016: $4.32 million | Q3 2016: $3.37 million | Q4 2016: $4.34 million | Q1 2017: $4.03 million | Q3 2017: $3.41 million | Q4 2017: $3.06 million | Q1 2018: $2.80 million | Q3 2018: $2.28 million | Q4 2018: $2.13 million | Q1 2019: $1.95 million | Q3 2019: $1.35 million | Q4 2019: $840.2 thousand | Q1 2020: $738.9 thousand | Q2 2020: -$448.00 | Q3 2020: $258.1 thousand | Q3 2020: -$12.5 thousand | Q4 2020: -$372.9 thousand | Q1 2021: -$955.1 thousand | Q2 2021: -$1.51 million | Q3 2021: -$2.20 million | Q1 2022: -$3.42 million | Q2 2022: -$4.26 million | Q3 2022: -$4.36 million | Q1 2023: -$5.28 million | Q2 2023: -$5.25 million | Q3 2023: -$5.58 million | Q4 2023: -$5.87 million | Q1 2024: -$6.15 million | Q2 2024: -$6.45 million | Q3 2024: -$6.64 million | Q4 2024: -$6.79 million | Q1 2025: -$6.97 million | Q2 2025: -$7.14 million | Q3 2025: -$7.31 million.
- Over the full 17 years of available data (2010 to 2024), Mosaic ImmunoEngineering Inc.'s Stockholders Equity has declined by 129.1%.
- Historical annual values: Fiscal year 2024: -$6.79 million | Fiscal year 2023: -$5.87 million | Fiscal year 2022: -$4.88 million | Fiscal year 2021: -$2.80 million | Fiscal year 2020: -$422.5 thousand | Fiscal year 2020: -$448.00 | Fiscal year 2020: $0.00 | Fiscal year 2019: $1.70 million | Fiscal year 2018: $2.50 million | Fiscal year 2017: $3.70 million | Fiscal year 2016: $3.75 million | Fiscal year 2015: $5.02 million | Fiscal year 2014: $6.51 million | Fiscal year 2013: $8.14 million | Fiscal year 2012: $7.09 million | Fiscal year 2011: $12.02 million | Fiscal year 2010: $23.35 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: